Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Eur J Cancer. 2019 Jul 20;118:142–148. doi: 10.1016/j.ejca.2019.06.009

Table 2.

Lung cancer and mortality at 10 years by randomization arm.

Total
(N=2,376)
Annual
(N=1,190)
Biennial
(N=1,186)
P-values
Lung cancer incidence 98 (4.1%) 58 (4.9%) 40 (3.4%) 0.0658
  Stage I 49 (50.0%) 31 (53.4%) 18 (45%) 0.4110
  Resected cancers 64 (65.3%) 43 (74.1%) 21 (52.5%) 0.0004
  Adenocarcinoma 55 (56.1%) 33 (56.9%) 22 (55.0%) 0.8525
  Interval cancers 27 (27.6%) 14 (24.1%) 13 (32.5%) 0.3625
  Lung cancers beyond 5 years 39 (39.8%) 23 (39.7%) 16 (40.0%) 0.9727
Total deaths a 137 (5.8%) 76 61 0.1936
Overall mortality rate (per 100,000) 593.5 659.7 527.6
Lung cancer deaths 40 (1.7%) 19 21 0.7417
Lung cancer mortality rate (per 100,000) 173.3 164.9 181.6
Other causes of deaths 94 56 38 0.0604
Other causes mortality rate (per 100,000) 407.2 486.1 328.7
Number of LDCTs performed 12,375 7,369 5,006
Number of LDCTs performed after baseline 10,072 6,217 3,855
Number of PETs performed 51 37 14
Benign lung resection 3 0 3
a

3 missing causes of death (1 Annual arm and 2 Biennial arm).